Skip to main content
. 2010 Jul 27;6:392. doi: 10.1038/msb.2010.46

Figure 3.

Figure 3

CB1 receptor antagonist treatment changes the distribution of tight junction proteins. Representative immunofluorescence staining for occludin and ZO-1 in obese ob/ob mice treated with vehicle (Ob-CT), CB1 receptor antagonist (SR141716A) (Ob-SR) (10 mg/kg/day) or pair fed (Ob-PF) for 12 days (n=6).